Royal Continental Hotel, Naples, Italy
December 5th - December 7th, 2019

Invited Faculty

Sanjiv Agarwala
Professor, Temple University, Philadelphia, Pennsylvania, US

Paolo A. Ascierto
Director, Medical Oncology, Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, National Cancer Institute Fondazione "G. Pascale", Naples, Italy

Christian Blank
Medical Oncology and Research Group Leader Tumor Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands

Gerardo Botti
Scientific Director National Cancer Institute “Fondazione G. Pascale”, Naples, Italy

Lisa H. Butterfield
Research Center Vice President, Parker Institute for Cancer Immunotherapy and Adjunct Professor of Microbiology and Immunology, University of California, San Francisco, California, US

Corrado Caracò
Chief of Surgery of Melanoma and Skin Cancer Unit, Dept of Haematology and Developmental Therapeutics, National Cancer Institute "Fondazione Pascale", Naples, Italy

Richard D. Carvajal
Director of Experimental Therapeutics and Director of the Melanoma Service, Columbia University Medical Center, New York City, New York, US

Sandra Demaria
Department of radiation oncology and pathology and laboratory medicine, Weill Cornell Medicine, New York, New York, US

Reinhard Dummer
Professor of Dermatology, University of Zurich Hospital, Department of Dermatology, Zurich, Switzerland

Alexander Eggermont
Professor of Oncological Surgery and General Director, Institut Gustave Roussy Villejuif, Paris-Sud, France

Marc Ernstoff
Professor and Chair, Department of Medicine, Roswell, Park Comprehensive Cancer Center Elm & Carlton, Buffalo, New York, US

Soldano Ferrone
Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, US

Bernard A. Fox
Chief of Laboratory of Molecular and Tumor Immunology, Robert W. Franz Cancer Research Center in the Earle A. Chiles Research Institute at Providence Cancer Center, Portland, Oregon, US

Thomas Gajewski
Oncology and Immunology Professor, Department of Pathology and Department of Medicine (Section of Haematology/Oncology), University of Chicago (Microbiome Center), Chicago, Illinois, US

Claus Garbe
Professor of Dermatology, Center for Dermatooncology, Department of Dermatology, Eberhard Karls University, Tuebingen, Germany

Jeffrey Gershenwald
Professor of Cancer Biology, Department of Surgical Oncology and Cancer Biology, Medical Director of Melanoma Skin Cancer, The University of Texas, MD Anderson Cancer Center, Houston, Texas, US

Jean-Jacques Grob
- Director Service de Dermatologie et Cancérologie Cutanée, Hopital de la Timone, Marseille, France

Valerie Guild
President at AIM at Melanoma Foundation, San Francisco Bay Area, San Francisco, California, US

Omid Hamid
Director, Clinical Research and Immunotherapy at The Angeles Clinic and Research Institute, Los Angeles, CA

Patrick Hwu
Department of Melanoma Medical Oncolgy, Division of Cancer Medicine, MD Anderson Cancer Center, Houston, Texas, US

Roger Lo
Professor of Dermatology, Melanoma Clinic in Dermatology, Jonsson Comprehensive Cancer Center David Geffen School of Medicine at UCLA, Los Angeles, California, US

Georgina Long
Co-Medical Director Melanoma Institute Australia, Professor of Melanoma, The University of Sidney and Royal North Shore Hospital, Sidney, Australia

Jason Luke
Director of the Cancer Immunotherapeutics Center, Associate Professor of Medicine, University of Pittsburgh Medical Center and Hillman Cancer Center, Pittsburgh, Pennsylvania, US

Mario Mandalà
Medical Director of Oncology Unit, “Papa Giovanni XXIII” Hospital, Bergamo, Italy

Giuseppe Masucci
Professor of Clinical Oncology, Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden

Olivier Michielin
Analytical Oncology Division Director, Oncology Department UNIL—CHUV, Lausanne, Suisse

Michael Postow
Memorial Sloane Kettering Cancer Center, New York City, New York, US

Igor Puzanov
Director, Early Phase Clinical Trials Program, Chief of Melanoma, Co-Leader, CCSG Experimental Therapeutics Program, Professor of Oncology, Department of Medicine, Roswell Park Comprehensive Cancer Center, Developmental Therapeutics, Buffalo, New York, US

Ryan Sullivan
Associated Director, Melanoma Program, MGH Cancer Center Harvard Medical School, Boston, Massachusetts, US

Janis M. Taube
Director of Division of Dermatopathology, Associate Professor of Drmatology and Pathology, John Hopkins University School of Medicine, Baltimore, Maryland, US

Alessandro Testori
Chairman gruppo chirurgico, EORTC Melanoma Group Senior Consultant, Fondazione IRCCS San Matteo, Pavia

Magdalena Thurin
Program Director, Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, NCI, NIH, Rockville, Maryland, US

Hassane Zarour
Professor of Medicine, Immunology and Dermatology, Co-Leader of Melanoma Program, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, US

Laurence Zitvogel
Research Director, Institut Gustave Roussy, Villejuif, Paris-Sud, France

For information please contact info@melanomabridge.org